Annals of Occupational and Environmental Medicine

  • Volume 35
  • /
  • Pages.38.1-38.10
  • /
  • 2023
  • /
  • 1225-3618(pISSN)
  • /
  • 2052-4374(eISSN)
The Korean Society of Occupational & Environmental Medicine (대한직업환경의학회)
권호 표지
DOI QR코드

DOI QR Code

Association between hearing loss and high-sensitivity C-reactive protein: the Kangbuk Samsung Cohort Study

  • Jihoon Kim (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Yesung Lee (Medical Support Division, Pyeongchang County Public Health Clinic) ;
  • Eunhye Seo (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Daehoon Kim (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jaehong Lee (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Youshik Jeong (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Seonghyun Kwon (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jinsook Jeong (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Woncheol Lee (Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • Received : 2023.06.05
  • Accepted : 2023.08.23
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Hearing loss (HL) is linked to an elevated risk of cardiovascular diseases (CVDs). The pathogeneses of HL and CVD commonly involve inflammatory responses. Previous studies investigated elevated levels of inflammatory biomarkers in subjects with HL, however, their findings did not demonstrate statistical significance. In our cross-sectional and longitudinal study, we investigated the correlation between HL and increased high-sensitivity C-reactive protein (hsCRP) levels to determine how HL is associated with CVDs. Methods: We conducted a cross-sectional study with workers aged over 18 years who underwent health check-ups at our institution between 2012 and 2018 (n = 566,507), followed by conducting a longitudinal study of workers aged > 18 who underwent health checkups at least twice at our institution between 2012 and 2018 (n = 173,794). The definition of HL was as an average threshold of ≥ 20 dB in pure-tone air conduction at 0.5, 1.0, and 2.0 kHz in both ears. The incidence of increased hsCRP levels throughout the follow-up period was defined as a level exceeding 3 mg/L. Logistic regression and generalized estimating equations were performed to estimate the risk of increased hsCRP levels according to the occurrence of HL in groups stratified by age. Results: In the cross-sectional study, the multivariate-adjusted odds ratio (OR) was 1.17 (95% confidence interval [CI]: 1.02-1.34); the OR was 0.99 (95% CI: 0.80-1.22) in those under 40 and 1.28 (1.08-1.53) in those over 40. In the longitudinal study, the multivariable-adjusted OR was 1.05 (95% CI: 0.92-1.19); the OR was 1.10 (95% CI: 0.90-1.35) in those under 40 and 1.20 (1.01-1.43) in those over 40. Conclusions: This cross-sectional and longitudinal study identified an association between HL and increased hsCRP levels in workers aged over 40 years.

Keywords

References

  1. Stevens G, Flaxman S, Brunskill E, Mascarenhas M, Mathers CD, Finucane M, et al. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health 2013;23(1):146-52.
  2. GBD 2019 Hearing Loss Collaborators. Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019. Lancet 2021;397(10278):996-1009.
  3. The Lancet. Hearing loss: an important global health concern. Lancet 2016;387(10036):2351.
  4. Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2018;144(2):115-26.
  5. Mener DJ, Betz J, Genther DJ, Chen D, Lin FR. Hearing loss and depression in older adults. J Am Geriatr Soc 2013;61(9):1627-9.
  6. Chen DS, Betz J, Yaffe K, Ayonayon HN, Kritchevsky S, Martin KR, et al. Association of hearing impairment with declines in physical functioning and the risk of disability in older adults. J Gerontol A Biol Sci Med Sci 2015;70(5):654-61.
  7. Friedland DR, Cederberg C, Tarima S. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk. Laryngoscope 2009;119(3):473-86.
  8. Lee W, Chang Y, Shin H, Ryu S. Hearing loss and risk of overall, injury-related, and cardiovascular mortality: the Kangbuk Samsung Health Study. J Clin Med 2020;9(5):1415.
  9. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83(2):456S-460S.
  10. Kurabi A, Keithley EM, Housley GD, Ryan AF, Wong AC. Cellular mechanisms of noise-induced hearing loss. Hear Res 2017;349:129-37.
  11. Fischer ME, Schubert CR, Nondahl DM, Dalton DS, Huang GH, Keating BJ, et al. Subclinical atherosclerosis and increased risk of hearing impairment. Atherosclerosis 2015;238(2):344-9.
  12. Frosolini A, Franz L, Daloiso A, Lovato A, de Filippis C, Marioni G. Digging into the role of inflammatory biomarkers in sudden sensorineural hearing loss diagnosis and prognosis: a systematic review and meta-analysis. Medicina (Kaunas) 2022;58(7):963.
  13. Gode S, Turhal G, Kaya I, Mavili HI, Kirazli T. Evaluation of procalcitonin and hs-CRP levels in sudden sensorineural hearing loss. J Int Adv Otol 2018;14(1):44-7.
  14. Gupta S, Curhan SG, Curhan GC. Biomarkers of systemic inflammation and risk of incident hearing loss. Ear Hear 2019;40(4):981-9.
  15. Banait T, Wanjari A, Danade V, Banait S, Jain J. Role of high-sensitivity C-reactive protein (hs-CRP) in non-communicable diseases: a review. Cureus 2022;14(10):e30225.
  16. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111(12):1805-12.
  17. Luan YY, Yao YM. The clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol 2018;9:1302.
  18. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336(14):973-9.
  19. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004;29(8):439-93.
  20. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347(20):1557-65.
  21. Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol 2016;111(8):1133-40.
  22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-9.
  23. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499-511.
  24. Guo Y, Liu J. The roles played by blood inflammatory parameters in sudden sensorineural hearing loss. Ear Nose Throat J. Forthcoming 2021.
  25. Masuda M, Kanzaki S, Minami S, Kikuchi J, Kanzaki J, Sato H, et al. Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2012;33(7):1142-50.
  26. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86(4 Pt 1):463-80.
  27. Humes LE. The World Health Organization's hearing-impairment grading system: an evaluation for unaided communication in age-related hearing loss. Int J Audiol 2019;58(1):12-20.
  28. Fuentes-Santamaria V, Alvarado JC, Mellado S, Melgar-Rojas P, Gabaldon-Ull MC, Cabanes-Sanchis JJ, et al. Age-related inflammation and oxidative stress in the cochlea are exacerbated by long-term, short-duration noise stimulation. Front Aging Neurosci 2022;14:853320.
  29. Tan WJT, Song L. Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss. Hear Res 2023;434:108783.
  30. Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017;2017:8416763.
  31. Marseglia L, Manti S, D'Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci 2014;16(1):378-400.
  32. Tan BL, Norhaizan ME, Liew WP, Sulaiman Rahman H. Antioxidant and oxidative stress: a mutual interplay in age-related diseases. Front Pharmacol 2018;9:1162.
  33. Hajar R. Framingham contribution to cardiovascular disease. Heart Views 2016;17(2):78-81.
  34. Watson N, Ding B, Zhu X, Frisina RD. Chronic inflammation - inflammaging - in the ageing cochlea: a novel target for future presbycusis therapy. Ageing Res Rev 2017;40:142-8.
  35. Cunningham LL, Tucci DL. Hearing loss in adults. N Engl J Med 2017;377(25):2465-73.